Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
28.01
-0.34 (-1.20%)
Aug 5, 2026, 10:23 AM EDT - Market open
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.79 billion as of August 5, 2026. Its market cap has increased by 49.58% in one year.
Market Cap
2.79B
Enterprise Value
1.86B
1-Year Change
49.58%
Ranking
Category
Stock Price
$28.01
ChartMarket Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.79B, an increase of 750.08%. That is a compound annual growth rate of 39.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 2.79B | 1.91% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 2.66B |
| Tarsus Pharmaceuticals | 2.64B |
| Immunome | 2.61B |
| Trevi Therapeutics | 2.54B |
| Kodiak Sciences | 2.49B |
| Ultragenyx Pharmaceutical | 2.46B |
| Nurix Therapeutics | 2.41B |
| Nektar Therapeutics | 2.38B |